Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surfactant replacement therapy: clinical and experimental studies.

D Vidyasagar1, T N Raju, S Shimada

  • 1Department of Pediatrics, University of Illinois at Chicago, College of Medicine.

Clinics in Perinatology
|September 1, 1987
PubMed
Summary

Surfactant replacement therapy shows promise for treating Hyaline Membrane Disease (HMD) in newborns. While not yet standard, ongoing research in animal models and clinical studies supports its potential therapeutic benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The GVK EMRI maternal and neonatal transport system in India: a mega plan for a mammoth problem.

Seminars in fetal & neonatal medicine·2015
Same author

Spontaneous CSF Rhinorrhea Our Experience.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2014
Same author

Effect of intrauterine repair of diaphragmatic hernia on the accompanying pulmonary hypoplasia in the fetal rabbit.

Pediatric surgery international·2013
Same author

Ingestion dose from 238U, 232Th, 226Ra, 40K and 137Cs in cereals, pulses and drinking water to adult population in a high background radiation area, Odisha, India.

Radiation protection dosimetry·2012
Same author

Spatial distribution of fallout 137Cs in the coastal marine environment of India.

Journal of environmental radioactivity·2012
Same author

Differences in thermal adaptation of infants delivered at primary or tertiary care facilities in India.

Journal of perinatology : official journal of the California Perinatal Association·2011

Area of Science:

  • Neonatal Medicine
  • Pulmonary Research
  • Biomedical Engineering

Background:

  • Hyaline Membrane Disease (HMD) is a significant cause of respiratory distress in premature infants.
  • Surfactant deficiency is a primary factor contributing to HMD pathogenesis.
  • Current treatments for HMD have limitations, driving the search for novel therapies.

Purpose of the Study:

  • To review the existing scientific literature on surfactant replacement therapy for HMD.
  • To evaluate the efficacy and safety of surfactant administration in preclinical and clinical settings.
  • To highlight the potential of surfactant therapy as a future treatment for HMD.

Main Methods:

  • Comprehensive literature search of animal models and human clinical trials.

Related Experiment Videos

  • Analysis of studies investigating different surfactant formulations and delivery methods.
  • Synthesis of data regarding treatment outcomes, including respiratory support and survival rates.

    • Main Results:

    • Extensive research in animal models demonstrates the physiological benefits of surfactant administration.
    • Clinical studies indicate promising outcomes, although widespread adoption is pending.
    • Variability in surfactant preparations and delivery protocols necessitates further standardization.

    Conclusions:

    • Surfactant replacement therapy is a promising therapeutic strategy for Hyaline Membrane Disease.
    • Further research and clinical trials are required to optimize treatment protocols and establish routine clinical use.
    • This therapy holds significant potential to improve outcomes for premature infants suffering from HMD.